A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors

Clinical trial NCT05453825 · UNKNOWN

Trial details

NCT number: NCT05453825
Sponsor: OncXerna Theraputics, Inc.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Triple Negative Breast Cancer Gastric Cancer Ovarian Cancer

Start date: 2022-08-05
Primary completion: 2024-04-15
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.